Group 1 - The core viewpoint of the article highlights that Guoen Technology (02768) has transferred shares from Morgan Stanley Hong Kong Securities to Huatai Hong Kong, with a market value of HKD 68.6328 million, accounting for 5.53% of the total shares [1] - Guoen Technology officially listed on the Hong Kong Stock Exchange on February 4, and was included in the Stock Connect on its first trading day [1] - The company specializes in chemical new materials and upstream and downstream products of gelatin and collagen, serving the chemical and health industries through research, production, and sales of industrial and commercial products [1] Group 2 - According to Frost & Sullivan, Guoen Technology is the second-largest organic polymer modified materials and organic polymer composite materials company in China by sales revenue, with a market share of 2.5% projected for 2024 [1]

Core Viewpoint - Guoen Technology (02768) experienced a decline of over 5% on its second day of trading, closing at HKD 37.94 with a transaction volume of HKD 117 million [1] Group 1: Company Overview - Guoen Technology officially listed on the Hong Kong Stock Exchange on February 4 and was included in the Stock Connect on its first trading day [1] - The company specializes in chemical new materials and upstream and downstream products of gelatin and collagen, serving both the chemical and health industries [1] - Guoen Technology is engaged in the research, development, production, and sales of products for industrial and commercial use [1] Group 2: Market Position - According to Frost & Sullivan, Guoen Technology is the second-largest organic polymer modified materials and organic polymer composite materials company in China by sales revenue, holding a market share of 2.5% as of 2024 [1]

Core Viewpoint - Guoen Technology Co., Ltd. officially listed on the Hong Kong Stock Exchange on February 4, with an initial offering price of HKD 36 per share, opening at HKD 45, a 25% increase, and a total market capitalization of approximately HKD 135 billion [1] Company Overview - Guoen Technology specializes in new chemical materials and upstream and downstream products of gelatin and collagen, serving the chemical and health industries [4][5] - The company was founded in 2000 by Wang Aiguo in Qingdao and has developed into a vertically integrated industrial cluster over more than 20 years [5][7] Financial Performance - Revenue projections for Guoen Technology are as follows: RMB 134 billion for 2022, RMB 174.4 billion for 2023, and RMB 191.9 billion for 2024, with net profits of RMB 7.2 billion, RMB 5.4 billion, and RMB 7.2 billion respectively [5][6] - For the first three quarters of 2025, the company reported revenue of RMB 154.97 billion and a net profit of RMB 7.21 billion [5] Business Segments - The company operates in two main segments: the large chemical segment, which accounts for approximately 95.6% of revenue, and the large health segment, which accounts for about 4.4% [6][7] - In the large chemical sector, Guoen Technology has established three main business engines: green petrochemical new materials, organic polymer modified materials, and organic polymer composite materials [7] IPO Details - The IPO saw a subscription rate of 2,251.85 times for the public offering, with 300,000 shares allocated, representing 10% of the total offering [4] - The international placement received a subscription rate of 10.03 times, with 27 million shares allocated, accounting for 90% of the total offering [4] Future Plans - Proceeds from the IPO will be used to establish a new production base in Thailand to expand capacity, produce organic polymer modified materials, and set up a regional headquarters to support international market expansion [8]

Core Viewpoint - Qingdao Guoen Technology Co., Ltd. (referred to as "Guoen Technology") has successfully listed on the Hong Kong Stock Exchange, closing at HKD 40.16 with an increase of 11.56% on the first day of trading [1]. Group 1: Company Overview - Guoen Technology specializes in the supply of new chemical materials and upstream and downstream products of gelatin and collagen [1]. - The company issued a total of 30,000,000 shares, with 3,000,000 shares available for public offering in Hong Kong and 27,000,000 shares for international offering [2]. Group 2: Financial Details - The final offering price was set at HKD 36.00, resulting in total proceeds of HKD 1,080.0 million. After deducting estimated listing expenses of HKD 79.6 million, the net proceeds amounted to HKD 1,000.4 million [2][3]. - The net proceeds from the global offering will be used for establishing a new production base in Thailand to expand capacity, enhancing the production capacity of the new base in Yixing, China, and general corporate purposes [3]. Group 3: Investor Information - Key cornerstone investors include Liguan Investment Co., Ltd., SLD International Enterprises Limited, and several others, with varying percentages of share allocation [5][6].

Group 1 - The core viewpoint of the article is that Guoen Technology (02768) has successfully listed on the Hong Kong Stock Exchange, with an initial share price of HKD 36 and a total issuance of 30 million shares, raising approximately HKD 1 billion in net proceeds [1] - As of the report, the stock price has increased by 25%, trading at HKD 45, with a transaction volume of HKD 248 million [1] - Guoen Technology specializes in new chemical materials and upstream and downstream products of gelatin and collagen, serving both the chemical and health industries [1] Group 2 - According to Frost & Sullivan, Guoen Technology is the second-largest company in China for organic polymer modified materials and organic polymer composite materials by sales revenue, holding a market share of 2.5% in 2024 [1] - The company is projected to be the largest producer of polystyrene in China by production capacity in 2024 [1] - On February 4, the Shenzhen Stock Exchange announced that Guoen Technology would be included in the Hong Kong Stock Connect securities list, effective from February 4, 2026, due to its listing on the Hong Kong Stock Exchange not being subject to the price stabilization mechanism [1]

Group 1 - The core viewpoint of the article is that Guoen Technology (02768) has successfully listed on the Hong Kong Stock Exchange, with an initial share price of HKD 36 and a total issuance of 30 million shares, raising approximately HKD 1 billion in net proceeds [1] - As of the report, the stock price has increased by 25%, trading at HKD 45, with a transaction volume of HKD 248 million [1] - Guoen Technology specializes in chemical new materials and upstream and downstream products of gelatin and collagen, serving both the chemical and health industries through research, production, and sales of industrial and commercial products [1] Group 2 - According to Frost & Sullivan, Guoen Technology is the second-largest company in China in terms of organic polymer modified materials and organic polymer composite materials by sales revenue, holding a market share of 2.5% in 2024 [1] - Additionally, Guoen Technology is projected to be the largest producer of polystyrene in China by production capacity in 2024 [1] - On February 4, the Shenzhen Stock Exchange announced that Guoen Technology would be included in the Hong Kong Stock Connect securities list, effective from February 4, 2026, due to the inapplicability of the price stabilization mechanism for its listing on the Hong Kong Stock Exchange [1]

Group 1 - The core viewpoint of the article is that Guoen Technology (02768) has successfully listed on the Hong Kong Stock Exchange, with an initial share price of HKD 36 and a total issuance of 30 million shares, raising approximately HKD 1 billion in net proceeds [1] - As of the report, the stock price has increased by 25%, trading at HKD 45, with a transaction volume of HKD 248 million [1] - Guoen Technology specializes in new chemical materials and upstream and downstream products of gelatin and collagen, serving both the chemical and health industries through research, production, and sales of industrial and commercial products [1] Group 2 - According to Frost & Sullivan, Guoen Technology is the second-largest company in China in terms of organic polymer modified materials and organic polymer composite materials by sales revenue, holding a market share of 2.5% in 2024 [1] - Additionally, Guoen Technology is projected to be the largest producer of polystyrene in China by production capacity in 2024 [1] - On February 4, the Shenzhen Stock Exchange announced that Guoen Technology would be included in the Hong Kong Stock Connect securities list, effective from February 4, 2026, due to its listing on the Hong Kong Stock Exchange not being subject to the price stabilization mechanism [1]

Investment Rating - The investment rating for the company is 5.5 out of 10, based on operational performance, industry outlook, valuation, and market sentiment [8]. Core Insights - The company is a leading supplier in China focused on chemical new materials and gelatin, with over 95% of its revenue coming from the large chemical sector. It ranks as the second-largest in organic polymer modified materials and organic polymer composite materials in China, holding a market share of 2.5% [1]. - The company has shown steady revenue growth, with projected revenues of approximately RMB 134.1 billion, 174.4 billion, and 191.9 billion for the years 2022, 2023, and 2024 respectively. In the first ten months of 2025, revenue reached RMB 174.4 billion, reflecting a year-on-year increase of 10% [1]. - The net profit attributable to shareholders for 2022, 2023, and 2024 was RMB 6.63 billion, 4.71 billion, and 6.85 billion respectively, with a significant increase of 40% year-on-year to RMB 7.12 billion in the first ten months of 2025 [1]. Company Overview - The company specializes in green petrochemical materials, including aromatic olefins, styrene, polystyrene, and organic polymer modified materials, which are applied in automotive, new energy, and home appliance sectors. It also operates in the health sector, producing gelatin, collagen, and hollow capsules [1]. - The global market for organic polymer modified materials and organic polymer composite materials is expected to grow at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2029, with China projected to grow at 14.1% [2]. Advantages and Opportunities - The company has established a strong market position in the organic polymer modified materials sector through a vertically integrated model and strategic expansion into the health sector, creating a dual growth engine under its "one body, two wings" strategy [3]. - It has a robust research and development capability, a strong reputation, and long-term partnerships with leading enterprises, supported by a visionary and experienced management team [3].

Core Viewpoint - The Hong Kong IPO market is experiencing a surge in demand, with Guoen Technology Co., Ltd. (referred to as "Guoen") launching its H-share offering, indicating strong investor interest and confidence in the company's growth potential [1][4]. Group 1: IPO Details - Guoen's H-share offering consists of 30 million shares, with approximately 10% allocated for public sale in Hong Kong and 90% for international investors [1]. - The price range for the H-share issuance is set between HKD 34 and HKD 42, with the public offering portion exceeding HKD 3.3 billion and an oversubscription rate of nearly 30 times [1][4]. Group 2: Investor Confidence - The cornerstone investor lineup for Guoen's IPO includes prominent institutions such as Liguan Investment, SLD International, and Luminous Horizon, collectively planning to subscribe for approximately HKD 320 million of the offering [4][5]. - The backing from these institutional investors reflects a strong market perception of Guoen's long-term value and growth prospects [5]. Group 3: Company Strengths - Guoen is recognized as the second-largest producer of organic polymer modified materials and organic polymer composite materials in China, and the largest producer of polystyrene by capacity [7]. - The company serves major clients in the home appliance, automotive, and new energy sectors, including Hisense, Midea, BYD, and CATL [7]. - In the health sector, Guoen controls Dongbao Biological, covering the entire industrial chain from gelatin raw materials to hollow capsules, ranking second in bone gelatin production and second among domestic brands in hollow capsule production in China [7]. Group 4: Fund Utilization - Guoen plans to allocate approximately 50% of the raised funds to establish a new production base in Thailand to expand capacity, while 35% will be used to enhance the production capacity of its Yixing facility [9]. - This strategic expansion aligns with the trend of downstream industries, such as home appliances and automotive, moving overseas, thereby opening new growth opportunities for the company [9].

Core Viewpoint - Guoen Technology (02768.HK) plans to globally offer 30 million H-shares, with 3 million shares available in Hong Kong and 27 million shares for international distribution, aiming for a price range of HKD 34.00 to 42.00 per share, with trading expected to commence on February 4, 2026 [2][3] Company Overview - Guoen Technology specializes in chemical new materials and gelatin, collagen, and related products, serving both the chemical and health industries [3] - The company operates in two main sectors: the large chemical sector, providing solutions to manufacturers in automotive, new energy, and home appliances, and the health sector, supplying raw materials for supplements and pharmaceuticals [3][4] Market Position - In the large chemical industry, Guoen is the second-largest company in China for organic polymer modified materials and organic polymer composite materials, holding a market share of 2.5% as of 2024 [4] - Guoen is also the largest producer of polystyrene in China by production capacity as of 2024 [4] Financial Performance - The company has shown strong revenue growth, with revenues of RMB 13.406 billion, RMB 17.439 billion, and RMB 19.188 billion for the fiscal years 2022, 2023, and 2024 respectively, reflecting a compound annual growth rate (CAGR) of 19.6% from 2022 to 2024 [7] - The sales figures for the fiscal years 2023 and 2024 indicate year-on-year growth rates of 30.1% and 10.0%, respectively [7] Market Trends - The market for organic polymer modified materials and organic polymer composite materials is projected to grow from RMB 303.8 billion in 2020 to RMB 544.8 billion by 2024, with a CAGR of 15.7% [8] - The market is expected to continue strong growth, reaching RMB 1,037.5 billion by 2029, with a forecasted CAGR of 14.1% from 2025 to 2029 [8] Use of Proceeds - The net proceeds from the share offering are estimated at approximately HKD 1.057 billion, with plans to allocate 50% for establishing a new production base in Thailand, 35% for expanding capacity in Yixing, and 10% for investments in Hong Kong [9]